A difficult first five years with the EU Paediatric Regulation
This article was originally published in SRA
Executive Summary
Mary Smillie concludes that the obligations this important piece of legislation places on the applicants of marketing authorizations for new products and line extensions are onerous and the incentive for off-patent products is insufficient.